Sopharma AD (SPH)
GPW
Closed
Oct 7, 2026
Day's Range
10.0052 wk Range
6.04Overview - SPH - Sopharma AD
Key Statistics
Valuation
Enterprise Value
25.49B
P/E (Trailing)
‪31.15‬
Price / Sales (TTM)
‪3.81‬
Price / Book
‪10.33‬
EV / EBITDA
‪50.50‬
Profitability
Gross Margin
‪22.67%‬
Profit Margin
‪5.85%‬
Operating Margin
‪5.63%‬
Return on Assets
‪4.98%‬
Return on Equity
‪17.19%‬
Ownership
Shares Outstanding
538.40M
Float
178.38M
Held by Insiders
‪66.41%‬
Held by Institutions
‪0.17%‬
Price stats
Beta
‪0.10‬
50-Day Avg
‪8.65‬
200-Day Avg
‪8.88‬
Dividends
Payout Ratio
‪142.49%‬
Frequency
Annual
Market Cap - SPH - Sopharma AD
Peers - SPH - Sopharma AD
Peer Comparison
Compared with companies in Medical Distribution listed on GPW.
- SPHGPWSopharma AD5.76BMarket Cap-19.16%52-week change31.15P/E (Trailing)‪5.85%‬Profit Margin
- NEUGPWNeuca S.A.3.19BMarket Cap+4.82%52-week change16.53P/E (Trailing)‪1.39%‬Profit Margin
- NVGGPWNovavis Group S.A.21.42MMarket Cap-106.86%52-week change172.00P/E (Trailing)‪204.81%‬Profit Margin
Profile Summary - SPH - Sopharma AD
About
Sopharma AD is a diversified pharmaceutical company based in Bulgaria, engaging in the development, production, and distribution of pharmaceutical products. Its primary function is to manufacture a wide range of healthcare solutions, including over-the-counter (OTC) medicines, prescription drugs, and nutritional…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
